These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21896130)

  • 1. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma.
    Gold MH; Biron J
    J Cosmet Dermatol; 2011 Sep; 10(3):189-96. PubMed ID: 21896130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
    Monheit GD; Dreher F
    J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
    Hantash BM; Jimenez F
    J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females.
    Katoulis A; Alevizou A; Soura E; Mantas N; Bozi E; Gregoriou S; Makris M; Rigopoulos D
    J Cosmet Dermatol; 2014 Jun; 13(2):86-90. PubMed ID: 24910270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
    Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
    J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
    Farshi S
    J Cosmet Dermatol; 2011 Dec; 10(4):282-7. PubMed ID: 22151936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma.
    Haddad AL; Matos LF; Brunstein F; Ferreira LM; Silva A; Costa D
    Int J Dermatol; 2003 Feb; 42(2):153-6. PubMed ID: 12709008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
    Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
    J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
    Pratchyapurit WO
    J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.